Trial Profile
A Multicenter, Randomized, Parallel-group, Open Study to Compare the Efficacy and Safety of Early Combination Therapy With Amaryl M to Metformin Uptitration in Type 2 DM Patients Inadequately Controlled on Metformin HCL
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Jun 2019
Price :
$35
*
At a glance
- Drugs Glimepiride/metformin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Handok Inc
- 07 Jul 2011 Status changed from recruiting to completed, based on presentation of results.
- 28 Jun 2011 Results presented at the 71st Annual Scientific Sessions of the American Diabetes Association.
- 18 Mar 2008 New trial record.